1. Home
  2. CLSD vs INTT Comparison

CLSD vs INTT Comparison

Compare CLSD & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLSD
  • INTT
  • Stock Information
  • Founded
  • CLSD 2011
  • INTT 1981
  • Country
  • CLSD United States
  • INTT United States
  • Employees
  • CLSD N/A
  • INTT N/A
  • Industry
  • CLSD Biotechnology: Pharmaceutical Preparations
  • INTT Semiconductors
  • Sector
  • CLSD Health Care
  • INTT Technology
  • Exchange
  • CLSD Nasdaq
  • INTT Nasdaq
  • Market Cap
  • CLSD 68.4M
  • INTT 77.3M
  • IPO Year
  • CLSD 2016
  • INTT 1997
  • Fundamental
  • Price
  • CLSD $0.35
  • INTT $7.21
  • Analyst Decision
  • CLSD Hold
  • INTT Strong Buy
  • Analyst Count
  • CLSD 4
  • INTT 2
  • Target Price
  • CLSD $4.33
  • INTT $12.00
  • AVG Volume (30 Days)
  • CLSD 582.0K
  • INTT 49.4K
  • Earning Date
  • CLSD 08-08-2025
  • INTT 10-31-2025
  • Dividend Yield
  • CLSD N/A
  • INTT N/A
  • EPS Growth
  • CLSD N/A
  • INTT N/A
  • EPS
  • CLSD N/A
  • INTT N/A
  • Revenue
  • CLSD $4,166,000.00
  • INTT $121,642,000.00
  • Revenue This Year
  • CLSD $98.20
  • INTT N/A
  • Revenue Next Year
  • CLSD $213.77
  • INTT $10.38
  • P/E Ratio
  • CLSD N/A
  • INTT N/A
  • Revenue Growth
  • CLSD N/A
  • INTT N/A
  • 52 Week Low
  • CLSD $0.29
  • INTT $5.24
  • 52 Week High
  • CLSD $1.65
  • INTT $9.77
  • Technical
  • Relative Strength Index (RSI)
  • CLSD 33.25
  • INTT 52.36
  • Support Level
  • CLSD $0.39
  • INTT $6.93
  • Resistance Level
  • CLSD $0.36
  • INTT $7.39
  • Average True Range (ATR)
  • CLSD 0.03
  • INTT 0.32
  • MACD
  • CLSD 0.00
  • INTT 0.03
  • Stochastic Oscillator
  • CLSD 14.77
  • INTT 58.59

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.

Share on Social Networks: